Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias

NCT04726241 is registered in ClinicalTrials.gov with PedAL BCU, LLC as lead sponsor.

NCT NCT04726241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Lead sponsor
PedAL BCU, LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 18, 2022
Completion date
December 31, 2030
Enrollment
960 (estimated)
Sites
184

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, acute myeloid leukemia post cytotoxic therapy, juvenile myelomonocytic leukemia, mixed phenotype acute leukemia, myelodysplastic syndrome, myelodysplastic syndrome post cytotoxic therapy, myeloid leukemia associated with down syndrome